Plain-English translation of NCT05192499 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers want to understand why some very young children (ages 1–3) have asthma that doesn't improve even with standard inhaled corticosteroid treatment. This exploratory study will compare samples of lung and digestive bacteria from children whose asthma is hard to control with those whose asthma responds well to medication. The goal is to discover whether an imbalance in these bacteria might be a hidden reason why some children struggle with severe asthma.
Standard asthma medications work well for most young children, but some toddlers have asthma that stays severe no matter how much medication they take. Recent research in other lung diseases suggests that the balance of bacteria in the lungs may play a role in how well treatments work. This trial aims to test whether that same idea applies to asthma in very young children.
You likely qualify if…
You likely don't qualify if…
If your child is enrolled, researchers will collect samples of lung secretions (or stool to check digestive bacteria) to analyze the bacteria present. Your child will be grouped either as having severe asthma (not well controlled on standard doses of inhaled corticosteroids) or mild-to-moderate asthma (well controlled on standard treatment). The study is observational, meaning researchers are watching and comparing, not testing a new medication — they simply want to understand the difference in bacteria between the two groups.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
France